|
García-Pérez D, López-Bellido R, Hidalgo JM, Rodríguez RE, Laorden ML, Núñez C, Milanés MV. Morphine regulates Argonaute 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neurons. Addict Biol. 2015 Jan;20(1):104-19. doi: 10.1111/adb.12083. PubMed PMID: 23927484.
AÑO: 2015; IF: 4.547
|
23927484
|
Lasheras MC, Laorden ML, Milanés MV, Núñez C. Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference. Neuropharmacology. 2015 Aug;95:168-80. doi: 10.1016/j.neuropharm.2014.12.021. PubMed PMID: 25556110.
AÑO: 2015; IF: 4.936
|
|
García-Pérez D, Núñez C, Laorden ML, Milanés MV. Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal. Addict Biol. 2016 Mar;21(2):374-86. doi: 10.1111/adb.12209. Epub 2014 Dec 17. PubMed PMID: 25522207.
AÑO: 2016; IF: 4.603
|
|
García-Pérez D, Luisa Laorden M, Núñez C, Victoria Milanés M. Glial activation and midkine and pleiotrophin transcription in the ventral tegmental area are modulated by morphine administration. J Neuroimmunol. 2014 Sep 15;274(1-2):244-8. doi: 10.1016/j.jneuroim.2014.07.017. PubMed PMID: 25108770.
AÑO: 2014; IF: 2.467
|
|
García-Pérez D, López-Bellido R, Rodríguez RE, Laorden ML, Núñez C, Milanés MV. Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal. Brain Struct Funct. 2015 Jul;220(4):1901-19. doi: 10.1007/s00429-014-0761-5. PubMed PMID: 24706046.
AÑO: 2015; IF: 5.811
|